Market revenue in 2021 | USD 282.1 million |
Market revenue in 2028 | USD 385.1 million |
Growth rate | 4.5% (CAGR from 2021 to 2028) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | CareSens Expert Plus |
Historical data covered | 2016 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 49.59% in 2021. Horizon Databook has segmented the Asia Pacific network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2016 to 2028.
The adoption of POC tests is rapidly increasing owing to their associated advantages such as fast, easy, and mobile diagnosis and self-monitoring. These products facilitate diagnosis and monitoring for patients at hospitals, health assessment centers, clinics, and home.
Developing healthcare infrastructure and high prevalence of diabetes are among factors expected to drive the market growth in Asia Pacific countries. Furthermore, rise in adoption of miniaturized models and various measures being taken for reducing stays in hospitals and clinics are expected to boost the demand for POC glucose testing products.
Adoption of POC glucose diagnostics in operating rooms, emergency rooms, intensive care units, path labs, and hospitals is expected to increase owing to early and efficient delivery of results.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific network point-of-care glucose testing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific network point-of-care glucose testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account